OQROGet OQRO Pro
Fund moves

Astrazeneca (AZN)Clark Capital Management Group, Inc. added to its stake +8,016 shares

Clark Capital Management Group, Inc. added to its stake in Astrazeneca, per its Q2 2026 13F.

608K
Shares reported · +8,016 vs prior quarter
0.63%
Disclosed portfolio weight
$115M
Reported value
Holdings as of
Jun 30, 2026
Filed
Aug 11, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

    What came next

    1. Sep 4, 2026FDAFDA drug approval: Etcamah
    2. Sep 14, 2026FDAFDA drug approval: Tagrisso
    3. Sep 16, 2026FDAFDA drug approval: Truqap
    View the official recordSEC Form 13F-HR

    How to read SEC Form 13F-HR

    Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

    Full guide: What is an SEC Form 13F?

    What else is on file for Astrazeneca

    For Astrazeneca, OQRO holds 62 fund holdings reports (13F) dated in the last 90 days.

    These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its AZN page.

    How this filing works

    Other disclosures at Astrazeneca

    Everything OQRO holds on this company is on its AZN page.

    This is one filing. OQRO holds the rest

    Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

    Unlock OQRO ProAlready have an account? Log in

    OQRO Pro is a paid subscription. You see the price before you pay

    OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data